POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 63 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $549,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $11,445,000 | 1.96% |
| Pentwater Capital Management LP | 4,967,227 | $54,490,000 | 0.66% |
| SECTORAL ASSET MANAGEMENT INC | 838,826 | $9,202,000 | 0.65% |
| Vivo Capital, LLC | 926,447 | $10,163,000 | 0.45% |
| Boxer Capital, LLC | 1,251,055 | $13,724,000 | 0.44% |
| Ikarian Capital, LLC | 250,837 | $2,752,000 | 0.12% |
| Perceptive Advisors | 787,745 | $8,642,000 | 0.09% |
| Rock Springs Capital Management LP | 289,754 | $3,179,000 | 0.07% |
| Regent Investment Management LLC | 20,000 | $219,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,450,268 | $15,909,000 | 0.04% |